glp 1 gip dual agonist mechanism of action Frontiers Mechanisms of action of GLP-1

29 GIP Agonism as a Potential Therapeutic Approach for Atherosclerotic Cardiovascular Disease The cardioprotective actions of incretin-based agents, particularly the GLP-1RAs, have a bulk of supporting evidence in the form of clinical studies

2023;38(11):2311-2315.e1

Combining high-protein meals with fiber-rich vegetables and whole grains creates a synergistic effect that maximizes your body's natural GLP-1 production

Telehealth obesity platforms including Hims and Hers , Ro , and Noom Med collectively supported more than 3.1 million active GLP-1 prescriptions as of Q1 2026 , delivering AI-powered dosage guidance, nutrition coaching, behavioral health support, and automated refill management within subscription platforms

CONCLUSION The expanding selection of glucose-lowering agents and the ever-increasing understanding of the impact of these agents on cardiovascular and renal outcomes provides an opportunity for pharmacy professionals to make a notable impact on patient care

doi: 10.1016/j.jacc.2024.06.001, PMID: [DOI] [PubMed] [Google Scholar] 27